|
Real-time Estimate
Cboe BZX
17:43:39 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 338.23 USD | -0.79% |
|
+4.57% | +0.64% |
| 10-16 | UBS Adjusts Price Target on Cencora to $400 From $430, Keeps Buy Rating | MT |
| 10-12 | Baird Adjusts Price Target on Cencora to $373 From $370 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.06B | |||||
| 181B | |||||
| 116B | |||||
| 113B | |||||
| 79.83B | |||||
| 54.35B |
- Stock Market
- Stocks
- COR Stock
- Charts Cencora, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
